Terms: = Breast cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
47 results:
1. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
[TBL] [Abstract] [Full Text] [Related]
2. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract] [Full Text] [Related]
4. (-)-Epicatechin Inhibits Metastatic-Associated Proliferation, Migration, and Invasion of Murine breast cancer Cells In Vitro.
Pérez-Durán J; Luna A; Portilla A; Martínez P; Ceballos G; Ortíz-Flores MÁ; Solis-Paredes JM; Nájera N
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687058
[TBL] [Abstract] [Full Text] [Related]
5. KK-LC-1 as a therapeutic target to eliminate ALDH
Bu J; Zhang Y; Wu S; Li H; Sun L; Liu Y; Zhu X; Qiao X; Ma Q; Liu C; Niu N; Xue J; Chen G; Yang Y; Liu C
Nat Commun; 2023 May; 14(1):2602. PubMed ID: 37147285
[TBL] [Abstract] [Full Text] [Related]
6. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage breast cancer.
Zhao F; Miyashita M; Hattori M; Yoshimatsu T; Howard F; Kaneva K; Jones R; Bell JSK; Fleming GF; Jaskowiak N; Nanda R; Zheng Y; Huo D; Olopade OI
JAMA Netw Open; 2023 Mar; 6(3):e233329. PubMed ID: 36995716
[TBL] [Abstract] [Full Text] [Related]
7. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
[TBL] [Abstract] [Full Text] [Related]
8. Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells.
Shilpa G; Lakshmi S; Jamsheena V; Lankalapalli RS; Prakash V; Anbumani S; Priya S
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):224-240. PubMed ID: 35750657
[TBL] [Abstract] [Full Text] [Related]
9. A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic breast cancer.
Lerner A; Keshwani K; Okines A; Sanderson B; Board RE; Flynn M; Sharkey E; Konstantis A; Roylance R; Hanna D; King J; Murphy R; Rehman F; Guppy AE; Westbury C; Takeuchi E; Spurrell E; Jayaweera HK; Raja F
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):261-266. PubMed ID: 35027287
[TBL] [Abstract] [Full Text] [Related]
10. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors.
Li Q; Jiang B; Guo J; Shao H; Del Priore IS; Chang Q; Kudo R; Li Z; Razavi P; Liu B; Boghossian AS; Rees MG; Ronan MM; Roth JA; Donovan KA; Palafox M; Reis-Filho JS; de Stanchina E; Fischer ES; Rosen N; Serra V; Koff A; Chodera JD; Gray NS; Chandarlapaty S
Cancer Discov; 2022 Feb; 12(2):356-371. PubMed ID: 34544752
[TBL] [Abstract] [Full Text] [Related]
11. Towards Taming the Bugs to Improve the Drugs for breast cancer.
Sharma D
Cancer Res; 2021 Apr; 81(8):1937-1939. PubMed ID: 34003771
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive breast cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract] [Full Text] [Related]
13. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive breast cancer.
Di Modica M; Gargari G; Regondi V; Bonizzi A; Arioli S; Belmonte B; De Cecco L; Fasano E; Bianchi F; Bertolotti A; Tripodo C; Villani L; Corsi F; Guglielmetti S; Balsari A; Triulzi T; Tagliabue E
Cancer Res; 2021 Apr; 81(8):2195-2206. PubMed ID: 33483370
[TBL] [Abstract] [Full Text] [Related]
14. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Huang C; Chen L; Savage SR; Eguez RV; Dou Y; Li Y; da Veiga Leprevost F; Jaehnig EJ; Lei JT; Wen B; Schnaubelt M; Krug K; Song X; Cieślik M; Chang HY; Wyczalkowski MA; Li K; Colaprico A; Li QK; Clark DJ; Hu Y; Cao L; Pan J; Wang Y; Cho KC; Shi Z; Liao Y; Jiang W; Anurag M; Ji J; Yoo S; Zhou DC; Liang WW; Wendl M; Vats P; Carr SA; Mani DR; Zhang Z; Qian J; Chen XS; Pico AR; Wang P; Chinnaiyan AM; Ketchum KA; Kinsinger CR; Robles AI; An E; Hiltke T; Mesri M; Thiagarajan M; Weaver AM; Sikora AG; Lubiński J; Wierzbicka M; Wiznerowicz M; Satpathy S; Gillette MA; Miles G; Ellis MJ; Omenn GS; Rodriguez H; Boja ES; Dhanasekaran SM; Ding L; Nesvizhskii AI; El-Naggar AK; Chan DW; Zhang H; Zhang B;
Cancer Cell; 2021 Mar; 39(3):361-379.e16. PubMed ID: 33417831
[TBL] [Abstract] [Full Text] [Related]
15. fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.
Pastushenko I; Mauri F; Song Y; de Cock F; Meeusen B; Swedlund B; Impens F; Van Haver D; Opitz M; Thery M; Bareche Y; Lapouge G; Vermeersch M; Van Eycke YR; Balsat C; Decaestecker C; Sokolow Y; Hassid S; Perez-Bustillo A; Agreda-Moreno B; Rios-Buceta L; Jaen P; Redondo P; Sieira-Gil R; Millan-Cayetano JF; Sanmatrtin O; D'Haene N; Moers V; Rozzi M; Blondeau J; Lemaire S; Scozzaro S; Janssens V; De Troya M; Dubois C; Pérez-Morga D; Salmon I; Sotiriou C; Helmbacher F; Blanpain C
Nature; 2021 Jan; 589(7842):448-455. PubMed ID: 33328637
[TBL] [Abstract] [Full Text] [Related]
16. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
[TBL] [Abstract] [Full Text] [Related]
17. Sequencing Endocrine Therapy for Metastatic breast cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?
Xi J; Ma CX
Curr Oncol Rep; 2020 May; 22(6):57. PubMed ID: 32415339
[TBL] [Abstract] [Full Text] [Related]
18. Predicting the likelihood of recurrence of pregnancy-associated breast cancer: Nomogram based on analysis of the French cancer network: cancer Associé à La Grossesse.
Larouzee E; Allegre L; Boudy AS; Ilenko A; Selleret L; Zilberman S; Owen C; Gligorov J; Richard S; Thomassin-Naggara I; Chabbert-Buffet N; Darai E; Bendifallah S
J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):101766. PubMed ID: 32325267
[TBL] [Abstract] [Full Text] [Related]
19. Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
Yuan S; Wang Y; Luo H; Jiang Z; Qiao B; Jiang Y; Hu Y; Cheng Y; Chen X; Gong W; Huang Y; Zhao W; Luo D; Liu B; Su H; Zhou J; Song S
Br J Haematol; 2020 Apr; 189(1):72-83. PubMed ID: 31960419
[TBL] [Abstract] [Full Text] [Related]
20. Loss of the fat1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.
Li Z; Razavi P; Li Q; Toy W; Liu B; Ping C; Hsieh W; Sanchez-Vega F; Brown DN; Da Cruz Paula AF; Morris L; Selenica P; Eichenberger E; Shen R; Schultz N; Rosen N; Scaltriti M; Brogi E; Baselga J; Reis-Filho JS; Chandarlapaty S
Cancer Cell; 2018 Dec; 34(6):893-905.e8. PubMed ID: 30537512
[TBL] [Abstract] [Full Text] [Related]
[Next]
